APA (7th ed.) Citation

DL, B., KL, M., KM, W., DP, L., PM, G., Z, D., . . . L, E. (2020). Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer. Cancer prevention research (Philadelphia, Pa.), 13(12), 979. https://doi.org/10.1158/1940-6207.CAPR-20-0186

Chicago Style (17th ed.) Citation

DL, Burkhart, Morel KL, Wadosky KM, Labbé DP, Galbo PM, Dalimov Z, Xu B, Loda M, and Ellis L. "Evidence That EZH2 Deregulation Is an Actionable Therapeutic Target for Prevention of Prostate Cancer." Cancer Prevention Research (Philadelphia, Pa.) 13, no. 12 (2020): 979. https://doi.org/10.1158/1940-6207.CAPR-20-0186.

MLA (9th ed.) Citation

DL, Burkhart, et al. "Evidence That EZH2 Deregulation Is an Actionable Therapeutic Target for Prevention of Prostate Cancer." Cancer Prevention Research (Philadelphia, Pa.), vol. 13, no. 12, 2020, p. 979, https://doi.org/10.1158/1940-6207.CAPR-20-0186.